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Purpose: The primary aims of this study were to delineate trends in medical comorbidity 
and surgical approach in patients with renal atherosclerosis and azotemia. 
Methods: We reviewed 1643 patients undergoing renovascular surgery between i970 and 
1993. We focused on those with the most advanced kidney disease (serum creatinine 
> 2 mg/dl) (n = 402). Attention was focused specifically on trends in sex, age, medical risk 
factors, surgical technique (bypass vs endarterectomy), and outcome including eventual 
need for long-term dialysis. 
Results: From 1970 to 1980, 652 patients underwent renovascular surgery, with 98 (15%) 
having a serum creatinine > 2 mg/di. From 1980 to 1993, the percentage ofpatients with 
renal insufficiency increased to 31% (304 of 991) (p < 0.001). Gender distribution did 
not change, but median age rose from 63.5 years in the first decade to 68.0 in the past 13 
years. A remarkable increase in all serious medical risk factors also occurred (first vs second 
decade). Another significant trend was a shift toward bilateral simultaneous transaortic 
endarterectomy (18% from 1980 to 1985 vs 53% from 1986 to 1993;p < 0.01), which 
simplified and achieved complete renal revascularization, especially in patients having 
multiple renal artery stenoses and those needing aortic grafting for occlusive or aneurysmal 
disease (56% from 1970 to 1980 vs 75% from 1980 to 1993). Patients at low risk (0 to 
1 comorbid medical conditions) had a 30-day mortality rate of 5.6% compared with 
patients at high risk (2 to 3 comorbid conditions) (15.5%)(p = 0.016). The eventual need 
for long-term dialysis remained low (9%) for patients with a preoperative s rum creatinine 
of 2 to 2.9 mg/dl compared with those with a serum creatinine greater than 3 mg/dl (35%, 
p < 0.01). 
Conclusions: In the past 20 years, there has been a remarkable increase in the medical 
comorbidity and extent of aortic disease in patients undergoing surgical revascularization 
for advanced renovascular hypertension and renal insufficiency. However, the surgical 
approach can be simplified and expedited by bilateral transaortic endarterectomy, and the 
risk of late dialysis can be reduced significantly by operating before the sermn creatinine 
exceeds 3 mg/di. (J VAse SURG 1995;21:750-60.) 
The true risks and benefits of renal revasculariza- 
tion for renovascular hypertension and chronic renal 
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insufficiency are still debated. In particular, this 
debate intensifies in the treatment of  elderly patients 
with diffuse atherosclerotic medical comorbidity, 
bilateral renal artery disease, and accompanying 
aortic disease (Fig. 1). 1-1~ Recent enthusiasm by 
some groups for renal balloon angioplasty and 
stenting has added to the therapeutic dilemma. 9'ni2 
So far, there have been no randomized clinical trials 
to ascertain the best therapy for patients with 
hypertension whose serum creatinine has risen above 
2 mg/dl. 
In 1987, we reported our experience from 1970 
to 1980 with 98 patients who had both hypertension 
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Figi ! ;  This 68~year:old man was ~dmitted wi~ uncontroiled hypertension, azotemia, and 
severe lower~e~mity ~!~fi~cati6n~ (A) lfixtarenai aortic occlusion, high'grade right renal 
artery stefi6SisiTand 16ft renai arte~ 6celuSiOfi~ (B) Right nephr0gram. Note minimal left 
nephrogram. (C) Lateral view of juxtarenal aortic occlusion. 
and chronic renal insuffidency? We were impressed 
with the significant medical comorbidity of these 
patients. Nonetheless, most benefited from surgical 
intervention by achieving reduction in antihyperten- 
slve side effects, stabilizing renal function, and 
gaining a 5-year survival rate of 64%. 
Between 1980 and 1993, the number of patients 
diagnosed with combined renovascular disease and 
impaired renal fimction increased. In fact, 304 of 991 
patients Who underwent renovascular reconstruction 
had a serum creatinine l vel greater than 2 mg/dl. To 
gain a contemporary profile of these patients, we 
analyzed the clinical factors affecting outcome. We 
specifically examined the trends in sex, age, medical 
risk factors, surgical technique (bypass versus endar- 
terectomy and aortic grafting), and outcome includ- 
ing need for long-term dialysis. These recent rends 
were compared with the trends of similar patients 
treated between 1970 and 1980. The primary goal 
was to identifv the risks and benefits of this high-risk 
group of patients with renovascular disease. 
METHODS 
Between 1980 and 1993, 991 patients underwent 
kidney operations at the Mayo Clinic for renovascular 
disease. Patients were identified from surgical ogs 
maintained prospectively b  each vascular surgeon in 
the Division of Vascular Surgery. All medical records 
were retrievable and contained the linked data 
collection for all outpatient and inpatient care. All 
patients who had a serum creatinine qual to or 
greater than 2 mg/dl (n = 3045 were selected for 
review. Essentially all of this subgroup had athero- 
sclerosis. None of these patients had fibromuscular 
disease. Patients with thoracoabdominal aneurysms 
with renal artery disease were also excluded. 
Data retrieval was organized into three time 
periods: preoperative patient profile, operative tech- 
nique, and postoperative outcome. Follow-up for 
this study was based on data available in the Mayo 
Clinic record. Late (5 to 10 years) outcome and 
survival analysis were not specific aims of this 
descriptive report of early surgical results (0 to 5 
years). 
The preoperative patient profile was constructed 
from age, sex, serum creatinine, systolic and diastolic 
blood pressure, number of antihypertensive m dica- 
tions, and selected risk factors that might influence 
operative morbidity and mortality rates. These risk 
factors included past myocardial infarction, angina 
pectoris, congestave heart failure, cercbrovascular 
disease (stroke or transient ischemic attacks), diabetes 
meltitus, and claudication. The same clinical criteria 
that were used to classify preoperative risk factors in 
our previously reported series (1970 to 1980) of 98 
patients with azotemia nd undergoing surgery were 
used for this study? This standardized approach was 
selected to allow comparison between our earlier 
series (1970 to 1980) and the current cohort (1980 
to 1993). Previous cardiovascular interventions were 
also recorded: renal balloon angioplasty, renal artery 
surgery, percutaneous coronary angioplasty, coro- 
nary artery bypass grafting, and carotid endarter- 
ectomy. 
Operative data were limited to the type of renal 
revascularization (bypass versus endarterectomy), 
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Table I. Patient characteristics for 1643 
renovascular operations 
Time period 
1970-1980 1980-1993 
No. of operations 652 991 
Age (yrs, median) 63.5 68.0 
Sex (male:female) 3 : 1 3 : 1 
Serum creatinine 554 (85%) 687 (69%) 
< 2 mg/dl 
Serum creatinine 98 (15%) 304 (31%) 
> 2 mg/dl *
*p < 0.001. 
nephrectomy, coincidental ortic replacement, and 
major postoperative complications. 
Outcome included the delineation of 30-day and 
90-day mortality rates, blood pressures, and serum 
creatinine at discharge and last follow-up, postoper- 
ative change in the number of antihypertensive 
medications, and need for long-term dialysis by last 
follow-up. 
Statistical tests for association with operative 
deaths were based on chi-square for dichotomous ri k 
factors and on the rank sum test for continuous 
factors. The p values below 0.05 were considered 
significant. 
RESULTS 
Between 1970 and 1993, 1643 kidney operations 
were performed at the Mayo Clinic for renovascular 
disease (Table I). During the first decade (1970 to 
1980), 652 renovascular operations were undertaken 
with 98 patients (15.5%) having a serum creatinine 
greater than 2 mg/dl. From 1980 to 1993, the 
percentage of patients with this level of azotemia 
increased to 31% (304 of 991) (p < 0.001). Thus 
the cumulative experience in the past 23 years with 
patients with azotemia undergoing renovascular 
surgery was 402 patients. 
Preoperative patient profile (Table I). The 
most recent 304 patients with azotemia (1980 to 
1993) included 218 men and 86 women with a 
median age of 68 years (range 32.5 to 84.9 years). 
Gender distribution has not changed in the past 23 
years. In contrast, he mean age has risen from 63.5 
years in the 1970s to 68.0 years in the 1980s 
(p < 0.05). 
The primary indication for renal revascularization 
was progressive r nal insufficiency (controlled hyper- 
tension) in 51% of patients and progressive azotemia 
and uncontrolled hypertension i 49%. Mean pre- 
operative serum creatinine was 3.29 mg/dl (2.0 to 9.6 
mg/dl) (Fig. 2). Creatinine ranged between 2.0 and 
2.9 mg in 174 patients and was greater than 3 mg/dl 
in 130 patients. Median systolic blood pressure was 
180 mm Hg (range 124 to 270) with diastolic 
pressure of 90 mm Hg (range 60 to 150). The 
median umber of antihypertensive m dications was 
three, with a maximum number of six. 
Several serious medical risk factors increased in 
prevalence between the two time periods (1970 to 
1980 vs 1980 to 1993) (Table II): past myocardial 
infarction (16% vs 27%), congestive heart failure 
(12% vs 24%), cerebrovascular disease (11% vs 
25%), claudication (36% vs 56%), and diabetes 
mellitus (7% vs 18%) (Table II). There was a trend 
toward more angina pectoris (21% vs 30%) (p = 
0.12). Fifty-two percent of patients had clinical 
evidence of heart disease (angina pectoris, past 
myocardial infarction, or congestive heart failure). 
Twenty percent of patients in the past 10 years have 
been hospitalized before operation with malignant 
hypertension, pulmonary edema, and renal insuffi- 
ciency. 
Previous cardiovascular interventions were also 
common after 1980. For example, the most frequent 
vascular procedures were coronary artery bypass 
grafting (16.4%), carotid endarterectomy (15.5%), 
prior renal artery surgery (14.2%), prior percutane- 
ous transluminal renal angioplasty (5.3%), and per- 
cutaneous transluminal coronary angioplasty (1.3%). 
Thus 19.5% of patients had previous attempts to 
revascularize r nal blood flow before referral for the 
current operation. Information on past cardiovascu- 
lar procedures was not recorded routinely in the 1970 
to 1980 database so no comparison could be made 
with the first decade. 
Operative techniques. A variety of operative 
combinations were used (Table III). In general, we 
preferred to achieve complete renal revascularization 
and aortic reconstruction for severe occlusive or an- 
eurysmal disease in a single procedure. Consequently, 
the following distribution occurred: bilateral revascu- 
larization (50%), unilateral revascularization (36%), 
and unilateral revascularization plus contralateral ne- 
phrectomy (14%) for a small (< 8 cm) nonrecon- 
structable kidney as a result of chronic renal artery 
occlusion and associated elevated renal vein renins. 
Concomitant aortic grafting was performed in75.1% 
of all patients compared with 55% between 1970 to 
1980. Although combinations ofocclusive and aneu- 
rysmal aortic changes coexisted in many cases, the 
operative reports indicated that the primary reason 
for aortic grafting was severe occlusive disease in 60% 
and aortic aneurysm in40% of patients. 
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Fig. 2. Distribution of preoperative s rum creatinine for 304 (serum creatinine >-2 mg/dl) 
patients with azotemia undergoing surgical renal revascularization (1980-1993). 
Table II. Medical comorbidity in 402 renovascular surgery patients with serum creatinine ___ 2 
mg/dl (1970-1993) 
1970-1980 1980-1993 
Risk factor (n = 98) (n = 304) p Value 
Angina pectoris 21.4% 29.9% 0.12 
Past myocardial infarction 16.3% 27.0% 0.04 
Congestive heart failure 12.2% 23.7% 0.02 
Cerebrovascular disease 11.2% 24.8% 0.01 
Diabetes mellitus 7.1% 18.1% 0.01 
Claudication 35.7% 56.4% 0.001 
Two noteworthy changes in surgical technique 
have occurred, Of the 304 patients, 68% had renal 
bypass grafting of some type, whereas 32% had 
transaortic renal endarterectomy. One of the main 
trends, however, was a shift toward bilateral si- 
multaneous transaortic renal endarterectomy (Fig. 3) 
in the past 7 years (18% from 1980 to 1985 vs 
53% from 1986 to 1993;p < 0.01). Average warm 
ischemia time during bilateral transaortic endarter- 
ectomy was 30 minutes (range 20 to 38). 
Outcome. The 30-day operative mortality rate 
for the entire 304 patients between 1980 to 1993 was 
10.2% compared with 7.1% between 1970 to 1980 
(NS). The mortality rate for men (11.0%) and 
women (8.1%) was similar (p = 0.456). Two clini- 
cal characteristics showed strong trends in predicting 
30-day mortality (p = 0.07) (Table IV): age ( < 70 
years vs > 70 years, 8.5% vs 14.3%) and preoperative 
serum creatinine (2.0 to 2.9 mg/dl vs > 3 mg/dl, 
7.5% vs 13.8%). The additive effect of three risk 
factors (age >70 years, clinically evident heart 
disease, and serum creatinine > 3 mg/dl) also influ- 
Table III. Operative combinations for 402 
patients with renovascular hypertension 
and chronic renal insufficiency 
1970-i980 1980-1993 
(n= 9~ (n= 304) 
Unilateral revascu- 38% 36% 
larization 
Unilateral revascu- 25% 14% 
larization plus 
contralateral ne- 
phrectomy 
Bilateral renal re- 26% 50% 
vascularization 
Nephrectomy alone 11% 0% 
Combined aortic 55% 75% 
grafting 
enced the 30-day mortality rate (Table V). Patients 
with low risk (no or one comorbid factor) had a 
mortality rate of 5.6% compared with 15.5% for 
patients with,high risk (two or three risk factors) 
(p = 0.016). 
The type and extent of the surgical procedure also 
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Fig. 3. (A) Preoperative aortogram shows severe bilateral ostial renal stenoses and infrarenal 
abdominal aortic aneurysm. (B) Postoperative arteriogram after bilateral transaortic renal 
endarterectomies and aortic tube graft. 
Table IV. Factors affecting 30-day operative mortality rates from 1980 to 1993 (n = 304) 
Factor Operative deaths (%) p Value 
Age group (yr.) 
< 70 8.5 0.07 
-> 70 14.3 
Sex 
Female 8. I 0.46 
Male 11.0 
Serum creatinine (mg/dl) 
2.0-2.9 7.5 0.07 
->3.0 13.8 
Angina 
Yes 11.3 0.57 
No 8.8 
Past myocardial infarction 
Yes 8.9 0.86 
No 9.7 
Congestive heart failure 
Yes 12.2 0.46 
No 8.9 
Diabetes mellitus 
Yes 8. i 0.74 
No 9.9 
Claudication 
Yes 11.0 0.40 
No 7.6 
Aortic graft 
Yes 11.8 0.07 
No 3.6 
affected the 30-day mortality rate. Concomitant 
aortic grafting increased the mortality rate (11.8%) 
compared with renal revascularization without aortic 
replacement (3.6%) (p = 0.07) (Table VI). In ad- 
dition, the 30-day mortality rate for those patients 
undergoing renal endarterectomy (4.3%) was lower 
than for those undergoing renal artery bypass graft- 
ing (12.2%) (p = 0.07). 
Both 30-day and 90-day mortality rates rose 
significantly with advancing age, regardless of asso- 
ciated comorbidity. In particular, the 30-day mortal- 
ity rate rose from 7.9% to 18.9% when comparing 
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Table V. Effect of multiple major comorbidities on 30-day operative mortality (n = 304) 
No. of 3 major 
% of patients risk factors* 30-day mortality p Value 
60.0%t Low-risk group 0 to 1 5.6% 0.016 
40.0%t High-risk group 2 to 3 15.5% 
~The three major risk factors were greater than age 70 years, clinically evident heart disease (angina pectoris, past myocardial infarction, 
or congestive heart failure), and serum creatinine greater than 3 mg/di. 
1-None of these risks were present in 18.6% of patients, whereas 41.4% had one major comorbidity. In the high-risk group (2 to 3 
comorbidities), 28.1% had two major risk factors, and 11.9% had all three major comorbidities. 
Table VI. Comparison of renovascular surgical patients (1980-1993) with and without aortic 
grafting (n = 304) 
Aortic grafting No aortic grafting 
(n = 228; zs%) (n = 76; 2S%) p Value 
Sex 
Male 78% 45% < 0.001 
Female 22% 55% 
Medical risk factors 
Angina pectoris 33% 20% 0.08 
Past myocardial infarction 27% 26% 0.63 
Congestive heart failure 21% 30% 0.26 
Cerebrovascular disease 28% 14% 0.05 
Diabetes mellitus 18% 18% 0.95 
Claudication 65% 30% < 0.001 
Previous urgery 
Renal artery surgery 11% 23% 0.02 
Renal balloon angioplasty 4% 9% 0.02 
Coronary artery bypass i6% 18% N.S. 
Coronary angioplasty 2% 0 N.S. 
Carotid endarterectomy 15% 18% N.S. 
Mortality rate 
30-day 11.8% 3.6% 0.07 
60-day 14.2% 5.4% 0.08 
90-day 16.0% 5.4% 0.04 
Change in serum crearinine 
Increase (-> 1 mg/dl) 23% 1I% 0.11 
Stable 51% 53% 
Decrease t -> 1 mg/dl) 26% 36% 
patients between age 50 to 65 with those older than 
75 years. Consequently, patient characteristics and 
outcome categorized by age groups are summarized 
in Table VII. 
Early postoperative deaths were generally the 
cumulative result of multiorgan failure. Specifically, 
the following complications occurred and accounted 
for morbidity and death: respiratory insufficiency re- 
quiring prolonged assisted ventilation ~ 13.5%), kid- 
ney failure requiring perloperative dialysis (11.2%), 
perioperative myocardial infarction (7.1%), gas- 
trointestinal complications (hemorrhage, perfora- 
tion, ischemia, 5.3%), systemic sepsis (4.7%), 
wound infection (4.1%), stroke (1.8%), and pulmo- 
nary embolism 10.6%). 
Several factors indicated better blood pressure 
control (Table VIII). First, median postoperative 
systolic pressure was 150 mm Hg (180 before 
operation) with diastolic pressure of 80 mm Hg (90 
before operation). These blood pressure levels were 
maintained at later follow-up too. This control was 
achieved with fewer antihypertensive medications 
(preoperative median of 3 vs postoperative median of  
2). Although only 44% of patients were receiving 
fewer than three antihypertensive drugs before op- 
eration, the conditions of 70% were improved, and 
the patients were receiving less than three drugs to 
control blood pressure after operation (p = 0.0005). 
Only 10~.9% of patients were cured, that is they were 
receiving no antihypertensive m dications and~had a 
diastolic blood pressure of 90 mm Hg or less. 
We interpreted a change m serum cre'atinine 
above 1 mg/dl to represent a clinically important 
change. Most (73%) patients had stabilization or 
improvement in renal function (twenty percent 
experienced a postoperative fall in creatinine more 
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Table VII. Descriptive statistics of 304 patients with azotemia (1980-1993) undergoing 
renovascular operations by age groups 
Age groups (yrs.) * 
50-65 65-70 70-75 > 75 
(n = 101) (n = 86) (n = 75) (n = 37) 
Sex 
Male (%) 67.3 
Female (%) 32.7 
30-day mortality rate (%) 7.9 
90-day mortality rate (%) 7.9 
Prior congestive heart failure 21.1 
(%) 
Angina pectoris (%) 22.5 
Past myocardial infarction (%) 21.1 
Cerebrovascular diseae (%) 22.5 
Diabetes meUitus (%) 17.1 
Change in creatinine 
Rise (_> 1 mg/dl) (%) 19.8 
Same (%) 51.5 
Fall (-> 1 mg/dl) (%) 28.7 
Preoperative creatinine (mg/dl) 3.12 _+ 0.13 
(median) 
Last follow-up creatinine 3.12 -+ 0.21 
(median) 
Mean follow-up (months) 23.0 
(2.6) 
(2.4) 
69.8 76.0 81.1 
30.2 24.0 18.9 
8.1 12.0 18.9 
12.8 16.0 24.3 
19.6 20.8 42.3 
32.1 37.7 26.9 
26.8 32.1 26.9 
26.8 24.5 19.2 
16.1 22.6 11.5 
18.6 24.0 16.2 
55.8 50.7 54.1 
25.6 25.3 29.7 
3.16 _+ 0.16 (2.2) 3.47 -+ 0.18 (2.8) 3.75 -+ 0.35 (2.6) 
3.37 --- 0.29 (2.3) 3.55 +- 0.26 (2.6) 3.28 -+ 0.31 (2.2) 
27.0 19.3 10.4 
*Five patients less than 50 years of age were excluded. 
than 1 mg/dl, whereas 53% remained unchanged). In 
contrast, 27% had a deterioration i creatinine of 
greater than 1 mg/dl. Long-term dialysis was begun 
on 4.6% of all 304 patients within 30 days. Subse- 
quently, another 13.5% needed long-term dialysis at 
a mean follow-up of 17.5 months. During this time 
period, the need for dialysis remained low (9%) for 
patients with a preoperative s rum creatinine of 2.0 
to 2.9 mg/dl, compared with those with a serum 
creatinine greater than 3 mg/dl (35%, p < 0.01). 
DISCUSSION 
The primary aims of this study were to delineate 
trends in medical comorbidity and surgical approach 
in patients with the complexities of renovascular 
disease and azotemia. This study has documented the 
increasing severity of the medical comorbidity in 
these patients. Because the renal artery lesions are 
usually bilateral and are frequently accompanied by 
aortic occlusive or aneurysmal disease, surgical cor- 
rection can be difficult and risky. 1"8'13"19 All of these 
variables complicate the design of randomized clini- 
cal trials for renovascular disease associated with 
azotemia. Consequently, this large retrospective s - 
ries offers current insight into the realistic risks of age 
and associated comorbid conditions in patients who 
undergo renal revascularization a d aortic replace- 
ment in the setting of widespread atherosclerosis and 
azotemia. 
Medical comorbidity. Increasing prevalence of 
medical risk factors should not be surprising. The 
population is aging rapidly, and better medical 
management has allowed more patients to survive 
into the advanced stages of atherosclerosis. Many of 
these medically managed patients, however, have 
decompensation eventually when certain clinical 
syndromes occur, lz,6a~ These include (1) malig- 
nant hypertension, kidney failure, and acute conges- 
tive heart failure, (2) atheroembofism to the kidneys 
and lower extremities, (3) large abdominal aortic 
aneurysms, or (4) severe incapacitating claudication 
or threatened limb loss. All of these clinical presen- 
tations can be complicated by the presence of renal 
artery stenoses and renal insufficiency. 
Medical comorbidity appears to account for most 
of the increased operative mortality rates. Other au- 
thors have also emphasized the serious cardiovascular 
conditions that accompany advanced renovascular 
disease, especially when combined aortic reconstruc- 
tion is necessary. 1~ With few exceptions, the 
mortality rate for combined aortic and renal recon- 
structions in the setting of chronic renal insufficiency 
ranges between 7% to 12%. 3,7s'13as When the surgi- 
cal reconstruction is complex or the serum creatinine 
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Table VIII, A. Postoperative outcome for 304 patients with renovascular hypertension 
BP control ~ 
Systolic BP (range) Diastolic BP (range) 
Preoperative 
Hospital discharge 
Follow-up 
180 (124-270) 
150 (96-190) 
146 (96-236) 
90 (60-150) 
80 (50,104) 
80 (46-112) 
BP, Blood pressure. 
*Median values. 
is greater than 3 mg/dl, higher operative mortality 
rates have been reported (31% to 43%). 14,~8 Thus our 
overall mortality rate of 10.2% in 304 patients over a 
13-year period is not unexpected. Furthermore, our 
current analysis indicates that patients at low risk have 
a mortality rate of 5.6% compared with 15.5% for 
individuals at high risk. 
Treatment options. When patients progress to 
uncontrolled renovascular hypertension and azo- 
temia, medical therapy has usually failed.~0,2 ~ Cur- 
rently, an increasing number of  such patients with 
ischemic nephropathy are reaching end-stage renal 
failure. 1~ Recent reports estimate tha( they com- 
prise 5% to 15% of new patients with end-stage r nal 
disease abovc age 50. In general, they fare poorly 
with longvterm dialysis. 26 
Although percutaneous renal balloon angioplasty 
is an option, the durability of  percutaneous translu- 
minal angioplasty for bilateral orificial lesions has 
been limited. 9,27 This marginal outcome is especially 
prevalent in patients with azotemia. We emphasize 
that 5% of our patients had already failed prior renal 
an io :iasty In an attempt to improve these results, g P 9 
renal stenting has been tried, but restenosis rates may 
still approach 30% to 40% in less than 1 year. I2 The 
presence Of metallic stents may also complicate any 
subsequent surgical repair. Stents may. Compromise 
the feasibility of proximal renal artery, inversion for 
endarterectomy and consequently force bypass grafts 
to the distal renal artery. 
In contrast, surgical renal revascularization has a 
well-documented record of effectiveness and dura- 
3~ bility. Because most patients have significant steno- 
sis or occlusion of both renal arteries, several opera- 
tive approaches are possible. The unilateral or staged 
approach (aortorenal, hepatorenal, splenorenal, i io- 
renal bypass) may suffice for patients with unilateral 
disease but may not optimally alleviate the hyperten- 
sion or kidney failure when multiple renal arteries are 
~References 1-8, 13-17, 19, 28-33. 
Table VIII, B. Postoperative outcome for 
304 patients with renovascular hypertension 
No. of antihypertens~ve 
medications Range 
Preoperative 3 0-6 
Hospital discharge 2 0-5 
Follow-up 2 0-5 
obstructed. In addition, the cumulative mortality 
rates of staged renal and aortic grafting (3% to 5% 
0 o per procedure) Can result in a 10 ~ to 15 ~ total death 
rate over time for an inception cohort. For many 
patients, asingle combined aortic and renal revascu- 
larization procedure may be the best long-term an- 
agement option, 
Consequently, we have adopted transaorfic renal 
endarterectomy for bilateral ostial stenoses, especially 
when significant aortic occlusive or aneurysmal 
disease also needs simultaneous correction. This 
technique is expeditious and anatomic 31 However, it 
does place more challenging technical demands on 
the surgeon. First; the renal arteries must be mobi- 
lized widely to  allow inversion endarterectomy. 
Second, the aortaup to and including the superior 
mesenteric artery must be exposed to facilitate safe 
suprarenal c amping, often above the superior mes- 
enteric artery. Third, the technical adequacy of the 
endarterectomies is ideallv assessed during operation. 
This assessment is made optimally by intraoperative 
color-flow duplex ultrasonography. In our reported 
experience, about 10% of arteries will have a residual 
plaque, intimal flap, or thrombotic occlusion eces- 
sitating revision.a4 Our operauve mortality rate of 
4.6% for transaortic endarterectomy, usually com- 
bined with simultaneous aortic grafting, is an im- 
provement over our overall mortality rate of l l .8% 
for all patients undergoing combined aortic and renal 
reconstruction. 
In addition to endarterectomy, we agree that a 
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Table VIII, C. Postoperative outcome for 304 patients with chronic renal insufficiency 
Renal function 
Serum creatinine (median) 
Preoperative 2.7 mg/dl 
Hospital discharge 2.2 mg/dl 
Later follow-up s 2.3 mg/dl 
Change in serum creatinine (% of patients) 
Increase ( -> 1 mg/dl) 27.3% 
Same ( < 1 mg/dl) 52.6% 
Decrease ( ->- 1 mg/dl) 20.1% 
Stable or improved 72.7% 
Long-term dialysis 
< 21 days after operation 4.6% 
> 21 days after operation s 13.5% 
*Mean follow-up of 17.5 months. 
variety of bypass techniques may be a better choice 
for certain patients. 7'13'3233 Like other surgeons, we 
have adopted extraanatomic bypasses (e.g., hepato- 
renal, splenorenal, iliorenal) in selected situations 
whr we do not opt to clamp or replace the 
aorta. ~3,3233 Although extraanatomic renal bypasses 
were used rarely by us before 1984, they currently 
comprise 15% to 20% of renal revascularizations i  
our patients with chronic renal insufficiency. 
Clinical outcome. Assessing the operative out- 
come for patients with advanced hypertension and 
renal insufficiency plus concomitant aortic disease can 
be complex. This complexity is created by interrelated 
surgical effects on blood pressure, renal reserve, and 
the aorta itself. Nonetheless, most appeared to ben- 
efit. Specifically, 70% of our patients had better blood 
pressure control while receiving fewer antihyperten- 
sive drugs, and an additional 11% were cured. In 
considering the effect on renal function, we selected 
relatively strict criteria for stabifity, deterioration or
improvement (i.e., change of 1 mg/dl up or down). 
With these criteria, the conditions of 73% of patients 
stabilized or had improvement of renal function. In 
particular, the risk of long-term dialysis remained low 
(9%) when preoperative creatinine was 2.0 to 2.9 
mg/dl compared with a baseline level greater than 3 
mg/dl (35%). In addition, 75% of patients had con- 
current relief of aortic disease causing incapacitating 
claudication, limb-threatening ischemia, or an ab- 
dominal aneurysm. 
When we consider the preoperative failure of 
aggressive medical management i  our patients and 
the multiplicity of medical comorbidities, we con- 
clude that the results are encouraging. Because we 
intentionally limited this study to review of Mayo 
Clinic records alone, our mean follow-up remains 
relatively short. Our previous Studies of patients with 
renovascular disease, however, confirmed the main- 
tenance of initial results and a 5-year survival rate of 
64%.3, 28 
In summary, analyzing a large group of surgical 
patients with both renovascular hypertension and 
chronic renal insufficiency has clarified three impor- 
tant concepts. First, the age and medical comorbidity 
of these patients are on the rise. Although comorbid 
factors (age > 70 years, creatinine > 3 mg/dl, and 
clinically evident coronary artery disease) increase 
operative mortality rates, these risks are not prohibi- 
tive for most patients. Second, surgical revasculariza- 
tion of bilateral or multiple ostial renal stenoses can 
be simplified and expedited by transaortic endarter- 
ectomy. Endarterectomy is an especially effective 
option when the aorta requires concomitant replace- 
ment. Finally, the best results of renal preservation 
occur when patients undergo complete surgical 
revascularization before serum creatinine xceeds 
3 mg/dl. 
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D ISCUSSION 
Dr.  Gerald Zelenock (Ann Arbor, Mich.). Renal 
revascularization i patients with hypertension who are 
otherwise healthy is a relatively low-risk undertaking. 
Conversely, the group of patients Dr. Hallett describes 
have very advanced generalized atherosclerotic disease and 
represent a high-risk population. Their renal artery disease 
has resulted in both severe hypertension and renal func- 
tional compromise, and revascularization is their best hope 
to avoid dialysis. When the combination of  their renovas- 
cular hypertension and kidney failure has been associated 
with and contributed to cardiac decompensat ion-the 
latter typically manifest as pulmonary edema-  they depend 
on correction of  their renal lesion for their very survival. 
Outcome comparisons with standard renal revasculariza- 
tions are inappropriate. In this report despite the severity of  
the renal vascular disease, the concomitant aortic disease, 
and a remarkable increase in the number and severity of  
medical comorbidities, the surgical outcomes have been 
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quite favorable and beneficial to the individual patients. An 
example from our own patient experience may help to 
illustrate. 
A 74-year-old woman was transferred to our hospital 
having had a seizure and stroke. Her blood pressure was 
220/160 mm Hg, her creatinine was 6.8 mg/dl, and her 
urine output was marginal. After arrival she had florid 
pulmonary edema. Despite maximal medical efforts to 
control her interrelated problems, she experienced recur- 
rent bouts of pulmonary edema and began undergoing 
dialysis. Bilateral transaortic renal endarterectomy resulted 
in immediate improvement in her blood pressure control, 
complete cessation of pulmonary edema nd restoration of 
urine output. At discharge 10 days after operation, her 
creatinine was 2.0 mg/dl. 
The patient was seen at follow-up 1 year after her 
operation. She is alert, oriented, and actively engaged in 
society. Her creatinine is 1.9 mg/dl, and her blood pressure 
is readily controlled. Like Dr. Hallett, our group has 
noticed a substantial change in our referral practice. 
Straightforward main renal artery revascularizations o 
longer form the bulk of  our renal work. Redo operations, 
complicated repairs involving secondary branches, chil- 
dren, and patients with severe concomitant aortic disease 
are the norm. We have also adopted transaortic endarter- 
ectomy or direct reimplantation asour preferred revascu- 
larization-techniques. 
Have you noticed this same increase in the anatomic 
and physiologic severity of illness in patients referred with 
other vascular problems? 
Dr. John W. Hallett, Jr. Dr. Zelenock and others have 
described the syndrome of malignant hypertension, azo- 
temia, and pulmonary edema. These patients are frequently 
confined to intensive care units and are receiving parenteral 
antihypertensive medication to control malignant hyper- 
tension and pulmonary edema. Some internists are reluc- 
tant to have surgeons undertake renal revascularization 
procedures on these critically ill patients. However, these 
patients can have an extraordinarily good response from 
surgical revascularization. 
The complexity of the conditions of patients with 
advanced renovascular hypertension is increasing, and in 
the area of renal work other than the patients with 
atherosclerosis, the complexity of the conditions i  increas- 
ing, and as with all referral centers the percentage of redo 
arid complex surgery of all kinds iS increasing, The 
increased use of angioplasty may actually keep some of 
these patients from us at the optimum time for surgery and 
we may not see them until they've undergone multiple 
angioplasties and then they will come to us with a much 
more difficult problem. 
Dr. Richard Pennell (St. Louis, Mo.). I often see 
patients who are quite elderly and who have extensive 
atheromatous disease of the aorta. It was interesting to 
notice your cutoff at the age of 70 years. It seems to me 
there are a lot of 50- and 60-year-old people who will 
tolerate transaortic endarterectomy quite well. The patient 
who is 75, 80, or 85 years old, with an isolated renal artery 
stenosis, who has extensive atheromatous disease involving 
the juxtarenal, or perhaps even suprarenal orta, may not be 
a good candidate for transaortic endarterectomy, as dem- 
onstrated by your increased' operative morbidity rate in 
these patients. 
What about extraanatomic revascularization? I have 
been particularly pleased with splenorenal nd hepatorenal 
bypass when unilateral reconstruction is required and the 
aorta seems to be a hostile environment. This is especially 
true in elderly patients at high risk. 
Dr. Hallett. Before 1984 we had performed no 
extraanatomic renal bypasses. In the last 10 years, we have 
adopted extraanatomic renal revascularization techniques 
in selected patients, especially the elderly patient hat Dr. 
Pennell mentions. I f  we do not elect to replace the aorta, 
some of these older patients can be treated by unilateral 
hepatorenal bypass, for example, with removal of a small 
pressor kidney. This operative combination can solve their 
problem without disturbing the aorta. So I agree that 
extraanatomic techniques can be useful in selected patients. 
But I tend not to use those less-than-complete revascular- 
izations in patients who are at better operative risk. Bilateral 
renal revascularization a d aortic replacement for serious 
occlusive or aneurysmal disease is our choice for a single 
operation in patients at better isk. 
Dr. Mark Adams (Milwaukee, Wis.). I notice that you 
didn't have any information about whether you had made 
an attempt o differentiate between renovascular insuffi- 
ciency as the main cause of elevated creatinine or some 
component of primary kidney disease. Could you comment 
on that, and would you make a statement regarding at what 
point in deterioration ofkidney disease based on creatinine 
clearance you would consider it not justified to proceed 
with this type of revascularization. 
Dr. Hallett. As you know, it's difficuk sometimes to 
tell hov< much of the patient's renal dysfunction is due 
to intraparenchymal arteriolar nephrosclerosis. We have 
found that proteinuria increases the likelihood that dialysis 
will be the eventual outcome. 
At what creatinine level do we not take people to the 
operating room? Some of the patients who benefit he most 
from renal reconstruction are those with the highest 
creatiuines but who also have a preserved, reasonable-size 
kidney (> 9 cm) beyond bilateral occlusions. So we look at 
the size of the kidney and fimction on the renal scan. If the 
patient has reasonable kidney parenchyma, we will attempt 
to revascularize the kidney despite the level of serum 
creatinine. 
